American Home Products Corporation
v.
Acaramba, Inc.
[Indexed as: American Home Products v. Acaramba, Inc.]
[Indexed as: ATIVAN.COM; LO-OVRAL.COM; OVRAL.COM]
WIPO Arbitration and Mediation Center
Administrative Panel Decision
Commenced: 31 May 2000
Judgment: 31 July 2000
Case No.: D2000-0457
Presiding Panelist: Jeffrey M. Samuels
Domain name - Domain name dispute resolution policy - U.S. Trademark
- U.S. Domain name - Identical - Confusingly similar - Rights or legitimate
interest - Bad faith registration - Bad faith use.
Complainant is owner of trademark registrations for ATIVAN, LO/ORVAL,
and OVRAL in association with medical products. Respondent registered
the domain names ATIVAN.COM, LO-OVRAL.COM, and OVRAL.COM. Respondent
did not file a response to complaint.
Complainant indicated that it contacted Respondent to demand that
the domain names be transferred to Complainant. Respondent later contacted
Complainant and offered to transfer or assign the domain names for expenses
in excess of any out-of-pocket costs. Complainant submits this fact and
the belief that Respondent has engaged in a pattern of such conduct, as
evidence of bad faith use and registration.
Held: Domain Name(s) Transferred
The Panel determines that Complainant has established all three elements
of proof. Respondent's domain names are legally identical to various
trademarks in which Complainant, through its prior use and registration
of those marks, has rights. The unrebutted evidence also indicates
that Respondent has no rights or legitimate interests in respect of the
domain name. With respect to the issue of bad faith registration
and use, the unrebutted evidence supports a determination that Respondent
registered the domain names for the purpose of transferring the names to
Complainant for valuable consideration in excess of the out-of-pocket costs
directly related to the domain names.
Policies referred to
Uniform Domain Name Dispute Resolution Policy, adopted August 26, 1999
Service Agreements referred to
Network Solutions, Inc. Service Agreement, effective November 29, 1998
Cases referred to
--
Panel Decisions referred to
--
1. The Parties
The Complainant in this administrative proceeding is American Home
Products Corporation, a corporation of the State of Delaware, U.S.A., with
its principal place of business at 5 Giralda Farms, Madison, New Jersey
07940, U.S.A. The Respondent is Acaramba Inc., of Boston, Massachusetts,
U.S.A.
2. The Domain Name and Registrar
The domain names in dispute are as follows: ativan.com; lo-ovral.com;
and ovral.com The domain names were registered by Respondent with Network
Solutions, Inc. on November 29, 1998.
3. Procedural Background
On May 18, 2000, the WIPO Arbitration and Mediation Center received
from Complainant a complaint (in hard copy) for decision in accordance
with the Uniform Policy for Domain Name Dispute Resolution, adopted by
the Internet Corporation of Assigned Names and Numbers (ICANN) on August
26, 1999 ("Policy"), the Rules for Uniform Domain Name Dispute Resolution
Policy, approved by ICANN on October 24, 1999 ("Rules"), and the WIPO Supplemental
Rules for Uniform Domain Name Dispute Resolution Policy (Supplemental Rules).
The complaint was filed in compliance with the requirements of the
Rules and the Supplemental Rules, payment was properly made, the administrative
panel was properly constituted, and the panelist submitted the required
Statement of Acceptance and Declaration of Impartiality and Independence.
The instant Administrative Proceeding was commenced on May 31, 2000.
Respondent did not file a response, and a "Notification of Respondent
Default", dated June 26, 2000, was forwarded by WIPO to Respondent.
The decision of the Panel was due to WIPO on or before August 1, 2000.
4. Factual Background
As set forth in the Complaint, Complainant owns the following U.S.
Trademark Registrations:
No. 875,020 for the mark ATIVAN, for medicinal preparation in the nature
of a psychotropic agent (date of first use, September 1967);
No. 1,005,211 for the mark LO/OVRAL, for steroidal gynecological preparation
(date of first use, June 1974); and
No. 1,194,195 for the mark OVRAL, for oral contraceptives (date of
first use August 1965). See Complaint, Exhibit C.
5. Parties' Contentions
Complainant contends that the domain names in issue were registered
or acquired primarily for the purpose of selling, renting, or otherwise
transferring the domain names to Complainant for valuable consideration
in excess of Respondent's out-of-pocket costs directly related to the domain
names. In support of such assertion, Complainant indicates that it contacted
Respondent, in February 1999, to demand that the domain names be transferred
to Complainant. Respondent later contacted Complainant and offered to transfer
or assign the domain names "for expenses" in excess of any out-of-pocket
costs. Respondent agreed to submit an itemization of such "expenses" to
Complainant, but, to date, has failed to do so.
Complainant further contends that the domain names were registered
in order to prevent the Complainant from reflecting the marks in corresponding
domain names and, upon information and belief, that Respondent has engaged
in a pattern of such conduct.
Finally, Complainant argues that the domain names are identical or
confusingly similar to marks in which Complainant has rights and that Respondent
has no rights or legitimate interests in respect of the domain names in
dispute.
6. Discussion and Findings
The Panel determines that Complainant has established all of the elements
required under 4.a. of the Policy.
Respondent's domain names are legally identical to various trademarks
in which Complainant, through its prior use and registration of the marks
ATIVAN, LO-OVRAL, and OVRAL, has rights.
The unrebutted evidence also indicates that Respondent has no rights
or legitimate interests in respect of the domain name.
With respect to the issue of bad faith registration and use, the unrebutted
evidence supports a determination that Respondent registered the domain
names for the purpose of transferring the names to Complainant "for valuable
consideration in excess of out-of-pocket costs directly related to the
domain name[s]," within the meaning of 4.b(i) of the Policy.
7. Decision
In view of the above, the Panel GRANTS Complainant's request for transfer
to it of the domain names ativan.com; lo-ovral.com, and ovral.com.
Jeffrey M. Samuels
Panelist
Dated: July 31, 2000
Domain Name(s) Transferred
Domain Names Transferred
|